Pettinga Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
775
+1
| +0.1% | +$389 | 0.07% | 108 |
|
|
2025
Q1 | $337K | Hold |
774
| – | – | 0.08% | 97 |
|
|
2024
Q4 | $285K | Buy |
774
+1
| +0.1% | +$369 | 0.06% | 109 |
|
|
2024
Q3 | $402K | Buy |
773
+1
| +0.1% | +$520 | 0.1% | 87 |
|
|
2024
Q2 | $418K | Hold |
772
| – | – | 0.1% | 83 |
|
|
2024
Q1 | $400K | Buy |
772
+1
| +0.1% | +$518 | 0.1% | 86 |
|
|
2023
Q4 | $364K | Sell |
771
-195
| -20% | -$92K | 0.1% | 91 |
|
|
2023
Q3 | $421K | Sell |
966
-315
| -25% | -$137K | 0.13% | 69 |
|
|
2023
Q2 | $569K | Hold |
1,281
| – | – | 0.17% | 54 |
|
|
2023
Q1 | $589K | Buy |
1,281
+1
| +0.1% | +$460 | 0.18% | 52 |
|
|
2022
Q4 | $657K | Hold |
1,280
| – | – | 0.21% | 59 |
|
|
2022
Q3 | $581K | Buy |
1,280
+312
| +32% | +$142K | 0.2% | 59 |
|
|
2022
Q2 | $467K | Buy |
968
+7
| +0.7% | +$3.38K | 0.14% | 68 |
|
|
2022
Q1 | $472K | Buy |
961
+6
| +0.6% | +$2.95K | 0.12% | 75 |
|
|
2021
Q4 | $443K | Buy |
955
+7
| +0.7% | +$3.25K | 0.11% | 78 |
|
|
2021
Q3 | $353K | Buy |
948
+8
| +0.9% | +$2.98K | 0.09% | 78 |
|
|
2021
Q2 | $359K | Buy |
940
+8
| +0.9% | +$3.06K | 0.1% | 77 |
|
|
2021
Q1 | $334K | Buy |
932
+8
| +0.9% | +$2.87K | 0.1% | 73 |
|
|
2020
Q4 | $297K | Buy |
924
+9
| +1% | +$2.89K | 0.11% | 70 |
|
|
2020
Q3 | $246K | Buy |
915
+8
| +0.9% | +$2.15K | 0.1% | 69 |
|
|
2020
Q2 | $239K | Buy |
+907
| New | +$239K | 0.12% | 67 |
|
|
2020
Q1 | – | Sell |
-800
| Closed | -$241K | – | 77 |
|
|
2019
Q4 | $241K | Buy |
+800
| New | +$241K | 0.13% | 76 |
|
|
2019
Q3 | – | Sell |
-789
| Closed | -$223K | – | 90 |
|
|
2019
Q2 | $223K | Buy |
789
+6
| +0.8% | +$1.7K | 0.12% | 85 |
|
|
2019
Q1 | $225K | Buy |
+783
| New | +$225K | 0.12% | 82 |
|